Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 3, 2011, Pages 295-301

  Seitz, Michael ^a   Gratzke, Christian ^a   Schlenker, Boris ^a   Buchner, Alexander ^a   Karl, Alexander ^a   Roosen, Alexander ^a   Singer, Bernhard B ^b   Bastian, Patrick J ^a   Ergün, Süleyman ^b   Stief, Christian G ^a   Reich, Oliver ^a   Tilki, Derya ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Contrast enhanced ultrasound; Diagnosis; Diagnostic accuracy; Microbubble contrast agent; Prostate; Prostate cancer; Transrectal ultrasound

Indexed keywords

SONOVUE;

ARTICLE; BLADDER CARCINOMA; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CYSTECTOMY; DIAGNOSTIC IMAGING; HUMAN; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; CONTRAST MEDIA; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ULTRASONICS;

EID: 79955739045     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.03.032     Document Type: Article

References (33)

1. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
2. Seitz M., Scher B., Scherr M., et al. Imaging procedures to diagnose prostate cancer. Urologe A 2007, 46:W1435-W1446.
3. Cornud F., Belin X., Piron D., et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: Impact on Gleason score for nonpalpable lesions. Urology 1997, 49:709-715.
4. Halpern E.J., Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000, 174:623-627.
5. Wijkstra H., Wink M.H., de la Rosette J.J. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol 2004, 22:346-350.
6. Smith J.A., Scardino P.T., Resnick M.I., et al. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. J Urol 1997, 157:902-906.
7. Jung J.A., Coakley F.V., Vigneron D.B., et al. Prostate depiction at endorectal MR spectroscopic imaging: Investigation of a standardized evaluation system. Radiology 2004, 233:701-708.
8. Wefer A.E., Hricak H., Vigneron D.B., et al. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000, 164:400-404.
9. Shimofusa R., Fujimoto H., Akamata H., et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005, 29:149-153.
10. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006, 241:449-458.
11. Kurhanewicz J., Vigneron D., Carroll P. Multiparametric magnetic resonance imaging in prostate cancer: Present and future. Curr Opin Urol 2008, 18:71-77.
12. Linden R.A., Trabulsi E.J., Forsberg F., et al. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol 2007, 178:2354-2358.
13. Salomon G., Kollerman J., Thederan I., et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: A comparison with step section pathological analysis after radical prostatectomy. Eur Urol 2008, 54:1354-1362.
14. Aigner F., Pallwein L., Mitterberger M., et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 2009, 103:458-463.
15. van Moorselaar R.J., Voest E.E. Angiogenesis in prostate cancer: Its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 2002, 197:239-250.
16. Frauscher F., Pallwein L., Klauser A., et al. Ultrasound contrast agents and prostate cancer. Radiologe 2005, 45:544-551.
17. Rifkin M.D., Zerhouni E.A., Gatsonis C.A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 1990, 323:621-626.
18. Clements R., Griffiths G.J., Peeling W.B. Staging prostatic cancer. Clin Radiol 1992, 46:225-231.
19. Scattoni V., Zlotta A., Montironi R., et al. Extended and saturation prostatic biopsy in the diagnosis and characterization of prostate cancer: A critical analysis of the literature. Eur Urol 2007, 52:1309-1322.
20. Seitz M., Shukla-Dave A., Bjartell A., et al. Functional magnetic resonance imaging in prostate cancer. Eur Urol 2009, 10.1016/j.eururo.2009.01.027.
21. Tsutsumi M., Miyagawa T., Matsumura T., et al. The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: Clinicopathological analysis. Int J Clin Oncol 2007, 12:250-255.
22. Pallwein L., Mitterberger M., Struve P., et al. Real-time elastography for detecting prostate cancer: Preliminary experience. BJU Int 2007, 100:42-46.
23. Yang J.C., Tang J., Li J., et al. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Acad Radiol 2008, 15:1291-1297.
24. Taymoorian K., Thomas A., Slowinski T., et al. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies. Anticancer Res 2007, 27:4315-4320.
25. Wink M., Frauscher F., Cosgrove D., et al. Contrast-enhanced ultrasound and prostate cancer: A multicentre European research coordination project. Eur Urol 2008, 54:982-992.
26. Unal D., Sedelaar J.P., Aarnink R.G., et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: The value of diagnostic predictors of prostate cancer. BJU Int 2000, 86:58-64.
27. Heijmink S.W., Barentsz J.O. Contrast-enhanced versus systematic transrectal ultrasound-guided prostate cancer detection: An overview of techniques and a systematic review. Eur J Radiol 2007, 63:310-316.
28. Engelbrecht M.R., Jager G.J., Laheij R.J., et al. Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 2002, 12:2294-2302.
29. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: Correlation with histopathologic results. Radiology 1997, 203:645-652.
30. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005, 234:804-814.
31. Uehara H. Angiogenesis of prostate cancer and anti-angiogenic therapy. J Med Invest 2003, 50:146-153.
32. Kumar V., Jagannathan N.R., Kumar R., et al. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging 2006, 24:541-548.
33. Tang J., Yang J.C., Li Y., et al. Peripheral zone hypoechoic lesions of the prostate: Evaluation with contrast-enhanced gray scale transrectal ultrasonography. J Ultrasound Med 2007, 26:1671-1679.